INTRODUCTION
Surgical site infections (SSI) account for a considerable proportion (20 to 31%) of healthcare-associated infections [1] [2] [3] and lead to increased morbidity, mortality, healthcare costs and length of hospital stay. 4 As reported to the National Healthcare Safety Network and the International Nosocomial Infection Control Consortium, the overall rate of SSI in adult patients is~2%, 1, 5 but far greater following high-risk surgeries such as exploratory abdominal surgery. 5, 6 Risk factors for SSI have been identified in predominantly adult populations and include hyperglycemia, prior infections, malnutrition, increased operative time and increased blood loss during surgery. [7] [8] [9] Neonates admitted to tertiary care neonatal intensive care units (NICU) often require surgery for complex congenital anomalies, particularly cardiac or gastrointestinal (GI) anomalies, and for complications of prematurity such as necrotizing enterocolitis or intraventricular hemorrhage. 10, 11 Infants may be at increased risk of SSI given their intrinsic immunodeficiency, immature skin, frequent need for medical devices, comorbid conditions and prolonged hospitalization. However, little is known about the incidence of and risk factors for SSI in the NICU population.
We performed a multicenter prospective cohort study to describe the epidemiology of SSI in the NICU population. In addition, we assessed potential factors associated with an increased risk of SSI, the perioperative antimicrobial prophylaxis regimens used, and management of SSI.
METHODS

Study design, study sites and study population
We used data collected from a multicenter prospective cohort study conducted from 1 May 2009 through 30 April 2012 at three academically affiliated Level III NICUs at The Children's Hospital of Philadelphia, The New York-Presbyterian Hospital Komansky Center for Children's Health at Weill Cornell Medical Center and The New York-Presbyterian Morgan Stanley Children's Hospital at Columbia University Medical Center. Infants were included in the current analysis if they were admitted to one of the study sites at o 7 days of age, remained hospitalized for at least 4 days and underwent one or more surgical procedures. Data from a subset of this cohort have been previously published. 12 Human subjects approval was obtained at each study site with a waiver of documentation of written informed consent. Parents at all study sites were provided an information sheet detailing the study.
During the study period, in fall 2010, a multidisciplinary committee to prevent SSIs throughout the hospital was formed at The Children's Hospital of Philadelphia. At the two New York-Presbyterian Hospital sites, a committee was formed in winter 2010 to reduce SSIs associated with cardiac surgery. Improvement efforts at all three sites focused on standardizing skin disinfection and perioperative prophylaxis.
Study definitions
SSI. The outcome of interest was an SSI documented by an attending neonatologist in the medical record and treated with intravenous antibiotics. If 41 SSI occurred in the same infant, only the first SSI was included in the analysis.
Type of surgery. Surgical notes were reviewed to determine the type of surgery performed and procedures were categorized as cardiac, neurosurgery, GI, congenital diaphragmatic hernia repair, ear-nose-throat, ophthalmological, genitourinary, orthopedic, pulmonary or other (for example, resection of lymphangioma and sternal cleft repair). If an infant had 41 surgical procedure, all were included and considered independently in the analysis; however, surgical procedures performed to treat an SSI (for example, debridement) and other surgeries occurring after an SSI were excluded.
Data collection
A structured data collection instrument was used to capture demographic data including gestational age, chronological age at surgery, sex, race, ethnicity, length of stay (LOS) and crude mortality from the medical record. Use of a central venous catheter (CVC) and chest tubes following cardiac surgery were collected.
The indications for the use of intravenous antimicrobial agents that were documented by attending neonatologists in the electronic medical record and the duration of use (calendar days) were collected, including perioperative administration for presumed surgical prophylaxis or to treat an SSI. Antimicrobial prophylaxis administered in the operating room was not collected, as intraoperative dosing was not reliably captured in the electronic medical record. When multiple surgeries were performed within 2 calendar days (for example, repeated reductions of a silo for gastroschisis), antimicrobial prophylaxis for subsequent surgeries was excluded from the analysis. For infants diagnosed with SSIs, surgical site and blood culture results as well as antimicrobial susceptibility data were collected.
Statistical analysis
All analyses were conducted using standard programs in Stata 13 (College Station, TX, USA). Categorical variables were summarized with frequencies and percentages. Continuous variables were summarized with medians and interquartile ranges (IQR). Chi-squared tests were used to identify differences in proportions for categorical variables. Mann-Whitney ranksum and Kruskall-Wallis tests were used to identify significant differences for continuous variables. To calculate lengths of stay (total and postoperative), only subjects who underwent one surgical procedure were included. Exact 95% confidence intervals were calculated for the rate of SSI by surgery type. Bivariate analyses were conducted to identify risk factors that were associated with SSI using logistic regression, adjusting by study site. Multivariate models were constructed to identify independent risk factors for SSI using all variables with a bivariate P-value o0.20, and were adjusted for clustering by NICU site. The effect of decreasing gestational age and younger chronological age at surgery was explored in the multivariate analyses by using the oldest gestational age and oldest chronological age in the data set as the reference value.
RESULTS
Surgical procedures and SSI rate
During the study period, 902 study subjects underwent 1346 surgical procedures that were included in this analysis. Forty-four procedures occurred after an SSI was diagnosed and were excluded. GI and cardiac procedures were the most common (46 and 28%, respectively) types of surgery (Table 1) . Differences in the types of surgery were noted among the sites. Cardiac surgeries were performed over twice as often as GI procedures at Site 1, whereas the number of cardiac and GI procedures was similar at Site 2. At Site 3, GI procedures were the most common type of surgeries performed, and cardiac procedures were relatively rare.
Overall, 60 (6.7%) of 902 subjects developed an SSI, for an overall incidence of 4.46 infections per 100 surgical procedures. The rate of SSIs did not differ significantly by type of surgery ( Table 1 ). The average time from surgery to diagnosis of an SSI was significantly longer for cardiac surgery (mean 16.2 days, median 14.0 days and IQR 3.0 to 27.0 days) than for GI surgery (mean 5.0 days, median 2.0 days and IQR 1.0 to 5.0 days) and neurosurgery (mean 3.0 days, median 2.5 days and IQR 1.5 to 5.0 days), but time to SSI was similar between cardiac surgery and congenital diaphragmatic hernia (CDH) repair (mean 22.3 days, median 2.0 days and IQR 2.0 to 62.0 days).
Of the 360 infants who had GI surgery, 86 underwent multiple GI procedures. The rate of SSI did not differ between initial and subsequent procedures (4.4 per 100 procedures (16/360) and 5.8 per 100 procedures (15/257), respectively; P = 0.44). The rate of SSI was 30.0% (6/20) among the subjects with silos placed for gastroschisis repair and 4.1% (3/74) for infants with necrotizing enterocolitis.
Preterm infants (o 37 weeks gestation) were more likely than term infants to develop an SSI after cardiac surgery (8.4 vies 2.9%, P = 0.03). The rate of SSI among preterm vies term infants was similar after neurosurgery (0% (0/34) vies 4.8% (4/84), respectively, P = 0.21).
Risk factors for SSIs
Multivariate analysis, adjusted for clustering by site, revealed the following independent risk factors for SSI: the use of a CVC, male sex, lower gestational age and younger chronologist age at time of first surgery ( Table 2 ). In Buford's analysis, lower birth weight was also associated with an increased risk of SSI (P = 0.02), but was not included in the multivariate model due to its co linearity with gestational age.
Impact of SSI on length of NICU hospitalization and crude mortality Among infants who underwent cardiac surgery, infants with an SSI had a longer overall NICU LOS (median 121.5 days vs 20 days, P o0.0001) and postoperative LOS (median 98.5 days vs 13 days, P o0.0001) than infants who did not develop an SSI. Similarly, among infants who underwent GI surgery, those with an SSI had a longer postoperative LOS than infants who did not develop an SSI (median 67.5 days vs 13 days, P o 0.0001). For other types of surgery, the overall and postoperative LOS was similar among those with and without SSI (data not shown). Among all infants undergoing surgery, the crude mortality rate was similar in infants with and without an SSI (6.7 vs 4.2%, P = 0.32).
Prophylactic antimicrobial agents for cardiac and GI surgical procedures Cefazolin was the most common agent used for both cardiac (80%, 271/339; Figure 1a ) and GI procedures (60%, 258/431; Figure 1b ). The most common alternative regimens for cardiac procedures included vancomycin alone or with other agents and the most common alternative regimen for GI procedures was piperacillin-tazobactam. The duration of perioperative prophylaxis varied among study sites for both cardiac and GI surgery (Table 3) . Infants undergoing cardiac procedures with a postoperative chest tube received a longer duration of prophylaxis when compared with infants without a chest tube (2 days, IQR, 2 to 4 days vs 1 day, IQR, 0 to 2 days, P o 0.0001).
Pathogens associated with SSI Fewer than half (43%, 26/60) of the infants with SSI had a culture obtained from the infected surgical site, although most cultures obtained were positive (77%, 20/26; Figure 2 ). The most commonly isolated organism was Staphylococcus aureus (50%, 10/20) and three infants had polymicrobial infection. Over half (60%, 36/60) had at least one blood culture obtained at the time of SSI diagnosis and all were negative.
Antibiotic management of SSI The average duration of intravenous antimicrobial treatment for SSI was 9.3 days (median 8, IQR 6 to 10.5 days) and was similar across the study sites (Kruskall-Wallis, P = 0.39). Among the 20 infants with positive cultures, 5% (1/20) received vancomycin for treatment of methicillin-resistant S. aureus and 5% (1/20) received meropenem for treatment of Enterobacter cloacae resistant to third generation cephalosporin agents. Among the 40 infants without pathogens identified, broad spectrum agents were commonly used; 62.5% (25/40) received vancomycin, 22.5% (9/40) received third generation cephalosporin agents and 2.5% (1/40) received meropenem.
DISCUSSION
In this multicenter study, 902 infants hospitalized in the NICU underwent 1346 surgical procedures and nearly one-quarter of infants underwent more than one procedure. The rate of SSI was 4.46 per 100 surgical procedures and overall, 7% of infants developed an SSI. We identified multiple risk factors for SSI including younger chronological and lower gestational age, male sex and use of a CVC. Although SSIs did not appear to increase the rate of mortality, they were associated with prolonged LOS. Finally we identified opportunities for improvement and standardization of the use of perioperative antibiotics and diagnostic evaluation of neonates with suspected SSI as discussed further below.
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Ampicillin/sulbactam, n=12 14 Furthermore, analysis of the Surgeons Congenital Heart Surgery Database and the Pediatric Health Information System found that the overall unadjusted rates of postoperative infections, including sepsis, wound infection, mediastinitis, endocarditis and pneumonia were 3.7%, but after adjustment for hospital-level patient characteristics and case-mix, the rate ranged from 0.9 to 9.8%. 15 The SSI rate in our cohort was similar for initial and subsequent GI tract procedures, but substantially higher among those who required multiple procedures to manage gastroschisis and had silos placed (30%). The Canadian Pediatric Surgery Network also demonstrated an elevated SSI rate of 14.2% among neonates with gastroschisis managed with silos. 16 We speculate that the complex management associated with reduction of gastroschisis which includes exposed bowel and large wounds puts these infants at high risk of SSI.
14 However, these surgical characteristics also make precise diagnosis of SSI difficult.
In our study cohort, each week decrease in gestational age increased the risk of developing an SSI by 14%. This increased risk could be due to the immunologic immaturity of preterm infants and immature skin structure. 17, 18 Similarly, younger chronological age could reflect these factors. 19 We also found that use of a CVC during hospitalization was associated with increased risk of SSI. We speculate that CVC is a marker for severity of underlying illness rather than part of the pathogenesis of SSI, but given that studies in neonates have shown an increase in risk of central line associatied bloodstream infection with catheter dwell times 42 weeks, 20 additional work should be done to determine if more prompt removal of a catheter may lead to a decreased risk of SSI as well. Within our cohort, the mean time from first insertion to last removal of a CVC was significantly longer among those with SSI (70 days vs 32 days, P o0.00001), though this is not a classical calculation of catheter dwell time as we only collected first insertion and last removal of CVC.
In this study, we did not find that infants with SSI had higher mortality rates, but they did have significantly longer overall and postoperative LOS compared with infants who underwent surgery without developing a SSI. Although we were unable to determine if the increase in LOS is attributable to SSI, it is feasible that infants with SSI do require treatment with intravenous antibiotics and/ or surgical debridement, may need longer durations of parenteral therapy due to associated feeding intolerance, and may be at increased risk of adverse drug reactions from treatment. [21] [22] [23] [24] Similar findings were noted by investigators in British Columbia; NICU patients with SSI were more likely to require further surgical procedures (median 2 procedures vs 1 procedure, P o 0.001) and had an increased length of hospitalization (median 79 days vs 25 days, P o 0.001) when compared with infants who did not experience an SSI. 14 In centers with high rates of postoperative infections following congenital heart surgery, patients with SSI experienced significantly higher adjusted LOS than those without SSI (25.5 days vs 11.2 days) and higher hospital costs ($1 15 000 vs $63 330). 15 Data from the Agency for Healthcare Research and Quality's National Inpatient Sample revealed that, in 2005, SSIs were responsible for 1 million additional days of hospitalization and $1.6 billion in attributable costs. 1 In the current study, only 43% of infants diagnosed with an SSI had a culture taken from the surgical site. Not having a positive culture from the infected site to guide therapy had an adverse clinical impact, as reflected in the increased use of broad spectrum antimicrobial agents in those with negative cultures or no cultures obtained. Among those infants with positive cultures, the most common organism isolated was methicillin-susceptible S. aureus. Thus, it is likely that many SSI without cultures were caused by methicillin-susceptible S. aureus, but treated with vancomycin that is a less effective agent for methicillin-susceptible strains. 25 Surgical teams should be educated about the benefits of obtaining cultures from a patient with a suspected postoperative wound 
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Other, n=10 infection. SSI were frequently caused by methicillin-susceptible S. aureus despite the common use of cefazolin as perioperative prophylaxis. We note that we did not evaluate appropriate timing and dosing of perioperative prophylaxis. Future studies should continue to assess SSI preventive strategies in infants including skin disinfection and the potential use of nasal and skin decolonization among infants colonized with S. aureus undergoing high-risk surgical procedures. 26 There are no evidence-based perioperative prophylaxis guidelines for infants and as a result, guidelines developed for adult populations are often used. Current guidelines for adult populations from the American Society of Health-System Pharmacists, the Infectious Disease Society of America and the Society of Hospital Epidemiology of America recommend cefazolin or cefuroxime for cardiac procedures unless there is a beta-lactam allergy, in which case vancomycin or clindamycin are recommended. Cefazolin is recommended for GI procedures without entry into the lumen, whereas other agents including cefotetan, cefoxitin and cefazolin+metronidazole are recommended for more complex procedures. These guidelines also suggest a maximum of 24 h of postoperative prophylaxis for non-cardiac procedures and 48 h for cardiac procedures. 27 Our findings suggest potential opportunities for standardizing perioperative prophylaxis and antimicrobial stewardship in the NICU population. Although cefazolin was the most commonly prescribed perioperative prophylactic agent used in the current study, many regimens were used, particularly for GI procedures. There were significant differences in length of perioperative prophylaxis; Site 1 prescribed a longer duration of prophylaxis for cardiac procedures and Site 3 prescribed a longer duration for GI procedures. Perioperative prophylaxis was significantly longer for cardiac procedures with postoperative chest tubes than procedures without chest tubes (P o0.00001). A recent double-blind placebo-controlled trial performed among patients undergoing elective thoracic surgery that required a chest tube demonstrated no difference in infectious complications among those who did and did not received antibiotic prophylaxis for chest tubes. 28 Furthermore, there is a risk of becoming colonized or infected with antibiotic resistant organisms from prolonged prophylaxis 29 and fewer infections with organisms such as Candida spp. and Pseudomonas spp. have been reported with shorter courses of antibiotic prophylaxis. 30, 31 Current surgical prophylaxis guidelines do not recommend continuing antibiotic prophylaxis until drains and chest tubes are removed. 27 Thus, our findings highlight the need for development of evidence-based practices for the NICU population.
There are limitations to our study. Our definition of SSI was somewhat subjective, relying on physician documentation in the electronic medical record instead of culture-confirmed infection or adjudication by infection prevention and control staff. Data were only gathered on antibiotics received in the NICU; therefore, we did not evaluate the pre-and intraoperative regimens. We did not collect the surgical wound class nor distinguish between superficial, deep and organ space infections. In addition, we did not collect information on the use of prosthetic material.
In conclusion, we found that SSI occurred after 4.46% of surgical procedures in the NICU population and that younger chronological age and lower gestational age were significant predictors of SSI. Our findings suggest several opportunities for improving antimicrobial stewardship including the need for developing evidence-based perioperative prophylaxis guidelines and SSI management in the NICU population.
